United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0363-0033_e5e90576-743d-4e41-8b6e-efa7fb5c9e4c
- Product NDC
- 0363-0033
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- WALGREEN CO.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200508
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 1200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (0363-0033-01) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0363-0033-01
- 2 BLISTER PACK in 1 CARTON (0363-0033-02) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0363-0033-02
- 3 BLISTER PACK in 1 CARTON (0363-0033-03) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 0363-0033-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →